Objective: We investigated the associations of morning and evening salivary cortisol levels with regional brain volumes and cognitive functioning in community-dwelling older persons without dementia.Method: From the Age, Gene/Environment Susceptibility (AGES)-Reykjavik Study, we included 4,244 persons without dementia (age 76 6 5 years, 58% women) who had 1.5T brain MRI, assessment of cognitive functioning, and saliva collected at home 45 minutes after awakening and at night. Linear regression analysis was used to estimate the cross-sectional relationship among cortisol levels, brain volumes, and cognitive functioning, adjusting for covariates.Results: Higher evening cortisol was associated with smaller total brain volume (highest vs lowest tertile 216.0 mL; 95% confidence interval 219.7 to 212.2 mL, adjusted for age, sex, education, intracranial volume, smoking, steroid use, white matter lesions, and brain infarcts on MRI). The smaller volumes were observed in all brain regions, but were significantly smaller in gray matter than in white matter regions. Poorer cognitive functioning across all domains was also associated with higher evening cortisol. Higher levels of morning cortisol were associated with slightly greater normal white matter volume and better processing speed and executive functioning, but not with gray matter volume or with memory performance.
Conclusions:In older persons, evening and morning cortisol levels may be differentially associated with tissue volume in gray and white matter structures and cognitive function. Understanding these differential associations may aid in developing strategies to reduce the effects of hypothalamic-pituitary-adrenal axis dysfunction on late-life cognitive impairment. With increasing age, the prevalence of dementia, including Alzheimer disease (AD), increases exponentially.1 At older age, depressive symptoms are also common, 2 often persist over years, 3 and are frequently comorbid with cognitive impairment and dementia. 4,5 Prospective studies indicate that depression may also increase the risk of future dementia. 6,7 Still, the neurobiologic substrate of the relation between depression and AD remains poorly understood. Several studies have found structural brain abnormalities to be associated with late-life depression, including hippocampal volume reduction. 8,9 Also, it has often been hypothesized that persistently high cortisol levels, often observed in depression, 10 have neurotoxic effects on the hippocampus.
6Because the hypothalamic-pituitary-adrenal (HPA) axis is inhibited by the hippocampus, 11 a cascade would occur in which age-associated hippocampal atrophy would lead to diminished ability to inhibit cortisol and, in turn, further atrophy of the hippocampus, 12 eventually leading to development of clinical dementia. Functional changes of the HPA axis have been observed in late-life depression. 13 However, relatively few studies have examined the association between